WallStSmart

Vuzix Corp Cmn Stk (VUZI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 4364% more annual revenue ($271.91M vs $6.09M). VUZI leads profitability with a 0.0% profit margin vs -14.7%. ZEPP earns a higher WallStSmart Score of 42/100 (D).

VUZI

Avoid

16

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.94

ZEPP

Hold

42

out of 100

Grade: D

Growth: 7.3Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 6/9Altman Z: 0.63
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

VUZIUndervalued (+40.2%)

Margin of Safety

+40.2%

Fair Value

$4.13

Current Price

$2.29

$1.84 discount

UndervaluedFair: $4.13Overvalued

Intrinsic value data unavailable for ZEPP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
33.8%10/10

Revenue surging 33.8% year-over-year

Areas to Watch

VUZI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$187.94M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-90.3%2/10

ROE of -90.3% — below average capital efficiency

ZEPP4 concerns · Avg: 2.5/10
Market CapQuality
$79.19M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.233/10

Elevated debt levels

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 33.8% demonstrates continued momentum.

Bear Case : VUZI

The primary concerns for VUZI are EPS Growth, Market Cap, Profit Margin.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Debt/Equity, Return on Equity.

Key Dynamics to Monitor

VUZI profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.84 — expect wider price swings.

ZEPP is growing revenue faster at 33.8% — sustainability is the question.

VUZI generates stronger free cash flow (-7M), providing more financial flexibility.

Bottom Line

ZEPP scores higher overall (42/100 vs 16/100) and 33.8% revenue growth. VUZI offers better value entry with a 40.2% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?